Watch-and-Wait Approach With Dostarlimab in Localized dMMR/MSI-H Gastric Cancer: GERCOR Phase II Study
Conditions: Adenocarcinoma - GEJ; Gastric Adenocarcinoma Intervention: Drug: Dostarlimab Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Research | Study